Abstract-This is a brief overview of the ideas of the possibility of using the cell kinetic model developed by the author in the 1980s to test, in experiments on cell cultures, potential geroprotectors and geropromoters that slow down or accelerate, respectively, the aging process in animals and humans. The history of the evolution of this model-from estimation of only the cell reproduction rate and saturation density in a non-subcultured cell culture to constructing survival curves in the stationary phase of growth and to a further analysis of the possible interrelation between all parts of the curve of cells' growth and subsequent dying out-is considered. Possible approaches to mathematical and statistical analysis of the data obtained within the framework of this model system are analyzed. It is emphasized that such studies can be carried out on cells of a very different nature (normal and transformed human and animal cells, plant cells, yeast, mycoplasmas, bacteria, etc.), which makes possible an evolutionary approach to the interpretation of the results obtained. At the same time, in the author's opinion, the most promising experiments are those carried out on immortalized cells of humans and animals, since they are not cancerous on the one hand and have an unlimited mitotic potential on the other hand and, therefore, do not "age" in the process of numerous divisions, as, for example, normal human diploid fibroblasts do. It is assumed that the appropriate mathematical analysis of the entire growth and dying out curve of a non-subcultured cell culture (from seeding into a culture flask to the complete death of all cells) may allow the clarification of certain relationships between the development and aging of a multicellular organism and to increase the reliability of identifying promising geroprotectors.
In the 1980s, I formulated the idea that the growth kinetics of cultured cells within a single passage can be used to estimate the "biological age" of the studied cells. This idea was based on the finding that the greater the age of the donor of human diploid fibroblasts, the lower the proliferation rate of these cells in culture and their saturation density [1] . This phenomenon is schematically illustrated in Fig. 1 . Similar data were obtained also for normal cells that undergo "aging" in vitro (i.e., change with an increase in the number of passages/divisions) [2] [3] [4] [5] . On the basis of these data, I have assumed that, by influencing cells cultured within a single passage (i.e., without subculturing) with one or another chemical or physical factor and analyzing the growth kinetics of this culture, it can be concluded with a certain probability whether this factor is a geroprotector or a geropromoter (a compound that decelerates or accelerates, respectively, the aging process of animals or humans). In this case, of course, it is necessary to provide the cells with physiologically optimal growth conditions (culture medium, serum, CO 2 content in the air, etc.). Otherwise, for example, any mitogenic or cytostatic agent might have a positive or negative effect, respectively, on the growth kinetics of cells. It was assumed that the factor of interest should not only just affect the proliferative characteristics of cells but also modify their viability. And the saturation density of the culture should be determined only by the contact inhibition of cells (which, from my point of view, is the most physiological method to restrict cell proliferation) rather than by the exhaustion of any resources in the culture medium or its modification by the proliferating cells. In this connection, a slight acidification of the medium in the stationary phase of growth, apparently, is not the key factor that restricts the proliferation of cells, eventually leading to their death [6, 7] . Unfortunately, ensuring such conditions is sort of a challenge, which imposes certain restrictions on this model system, which I called the "cell kinetic model to test potential geroprotectors and geropromoters" [8] [9] [10] .
In addition, on the basis of certain "evolutionary" ideas, I assumed that the above considerations must be true not only for the normal cultured cells with a lim-ited mitotic potential, which obey the Hayflick limit, but also for transformed animal and human cells, bacteria, yeast, mycoplasmas, plant cells, etc.
It should be emphasized that, as I have already repeatedly noted, the term "saturation density of cell culture" in the literature is often either not clearly defined or replaced with other terms with a vague meaning. For example, Gazzola et al. [2] , who studied skin fibroblasts of a 16-year-old girl, found a strictly inverse correlation between the number of cell population doublings in the culture and "the cell density in the confluent monolayer culture." Unfortunately, this expression does not tell us what exactly was measured in the study, because there are no clear criteria for the "confluency" of cells. We prefer to use the expression "the saturation density of a cell culture," which is understood as the density of cells in culture at which they completely cease to proliferate. In this context it should be noted that the value of this parameter may vary greatly for different cells and is, apparently, determined by fine intercellular contact mechanisms [11] .
In this connection, the data are also of interest that some steroid hormones that increase the lifespan of human diploid fibroblasts in vitro (the Hayflick limit) cause changes in the growth kinetics of these cells, indicating their "rejuvenation" [12, 13] . In addition, in some cases, a change in the growth kinetics of human cells in vitro may be indicative of certain diseases and pathological processes in their donor [14] .
To approximate the growth curves of the studied cell cultures, we used the Verhulst-Pearl equation [8] [9] [10] :
In this formula, N t is the number of proliferating population at time t; N 0 is the population size at time zero; r m is the instant birth rate (r), which is defined as at a low population density (i.e., the maximum possible value of r); and K is the height of the "plateau" on the population growth curve (its saturation density).
Since not all cells seeded in a flask or in a Petri dish can adhere to the growth surface and start to proliferate, in Eq. (1) we replaced N 0 (the number of seeded cells) with N 1 (the number of cells adhered to the growth surface 1 day after seeding). In view of this, all growth curves in our study were built starting exactly with their 24-h point. It should be noted that, in the case of suspension cultures, such modification of the formula, apparently, does not make sense, because cells can begin to proliferate almost immediately after seeding in a fresh medium.
By inputting the experimental data describing the increase in the cell culture density with time into appropriate software, we can use nonlinear regression to obtain the estimates of all three parameters (N 1 , K, and r m ), which are required for the construction and subsequent analysis of the kinetic curves. Attempts to select parameters K and r m after entering a specific experimentally obtained N 1 value into the computer showed that this approach worsens the matching of the obtained function to the experimental data.
A number of experiments performed by me and my colleagues on normal and transformed cultured human and animal cells showed that, indeed, the geroprotectors and geropromoters that were discovered in gerontological studies on experimental animals behaved themselves "properly" when tested in our model. However, the cell proliferation rate (r m parameter) in some cases did not change as expected, whereas the saturation density of the culture (the "plateau" in the growth curve, parameter K) usually linearly depended on the studied factor dose, increasing and decreasing under exposure to geroprotectors and geropromoters, respectively. Certainly, as noted above, the cytostatic or mitogenic effects of the studied drugs/radiation of different types cannot be completely ruled out; nevertheless, in the experimental gerontological studies on animals, these factors may realize their effect exactly in this way. However, the fact that, in some experiments, geroprotectors increased the height of the "plateau" but did not affect the cell proliferation rate suggests that this effect was not due to the mitogenic action of the studied compounds.
The results of our studies performed in the 1980s are described in a number of papers and summarized in my monograph [15] and respective review [10] . Using the cell kinetic model, we have tested a large number of chemical and physical factors, such as Although most of our experimental data confirm our assumption that the geroprotectors and geropromoters revealed in animal experiments behave "properly" in our cell kinetic model, this model system, similarly to the Hayflick model, seems to be "correlative" [16] . In other words, the obtained data seem to have nothing to do with the actual mechanisms of aging and only reflect some correlations. This situation is similar to the well-known dependence of the number of gray hairs on a human head on age, which does not at all correlate with the death probability [17] .
In view of this, we focused in subsequent years on another cell model, which was called the "stationary phase aging model." Since the gist of it was described in detail in a number of our publications (see, e.g., [18] [19] [20] [21] [22] [23] [24] , etc.), here I will not go into its thorough description. It should only be noted that, having considered this model to be "essential," we used it to estimate the accumulation of various "age-related" changes in the stationary culture of normal or transformed animal or human cells. It turned out that these changes, indeed, almost always coincide with the changes in the cells of an aging multicellular organism. However, the kinetics of cell death in the stationary phase of growth first remained "behind the scenes." Later, however, taking into account the results of the studies of the "chronological aging" of yeast and bacteria [25] [26] [27] [28] , we obtained a number of respective survival curves for cells in the stationary phase of growth in a non-subcultured culture. Mathematical analysis of these curves showed that these cells died in a good agreement with the Gompertz formula ( Fig. 2 ; schematic illustration is based on the results of several of our experiments) [29] . In this regard, we later performed a series of studies aimed at analyzing the influence of certain biologically active compounds particularly on the kinetics of the death of cultured cells in the stationary phase of growth (see., e.g., [7, [29] [30] [31] [32] [33] ). It was assumed that the deceleration of this process can serve as a basis for classifying the agent of interest as a geroprotector [34, 35] . All experiments were performed on the line of transformed (yet capable of contact inhibition) Chinese hamster cells, which was studied well in our laboratory. We believed that a change in the viability of cells under the influence of a geropromoter/geroprotector (if the latter does not selectively affect cancer cells) leading to acceleration/deceleration of the death of cells during their "stationary phase aging" should not principally depend on the type of cells used in experiment; because of this we did not use normal fibroblasts.
However, as was noted in one of our previous publications [36] , we often see criticism of the models used in our laboratory due to the fact that the majority of experiments on testing geroprotectors are performed on the transformed rather than normal mammalian cells. However, this selection of the test object seems quite substantiated to us for the following reasons. I have already pointed out above that the phenomenon of the stationary phase/chronological aging is peculiar to most diverse cells, including bacteria, yeast, cyanobacteria, mycoplasmas, animal and plant cells. And the "replicative age" of cells with an unlimited mitotic potential changes neither from experiment to experiment nor during long-term cultivation both with and without (in the stationary phase aging model) subcultivation. This is not characteristic of the normal diploid fibroblasts, whose telomeres shorten with each cell division (note that, in the period from seeding until entering the stationary growth phase, cells may divide up to ten times!). Thus, the normal cells that enter the "plateau" stage will have a much higher "replicative age" than the cells at the time of seeding. As a result, their further changes may be determined not only by the stationary phase aging, which is of interest for us. For the same reasons, it is problematic to correctly repeat experiments because normal cells in mass culture permanently change with time. Finally, we often perform the so-called "crosssectional" experiments, in which cells are seeded in culture flasks at certain (sometimes quite large) time intervals and are used for evaluating the study parameters in the same particular time, when different groups of flasks contain cells with different "stationary phase age." Work with normal fibroblasts, which "count" passages, makes it almost impossible to ensure the identity of all groups of seeded cells. In this case, as the saying goes, "no one can step twice into the same river" [37, 38] .
It cannot be ruled out that a "combined" cell kinetic model, which includes all parts of the cell growth curve and subsequent cell death in the stationary phase of growth, will make it possible to shed light on the long-known (since the 18th century) relationship between the duration of the developmental period of mammals and their maximum lifespan (see., e.g., [39] [40] [41] ). As in the case of higher animals, cells in our model first proliferate very quickly ("embryonic development"), then the mean proliferation rate multiply decreases until the cell population size stops to change ("completion of development of the organism"), and, eventually, the nondividing cells begin to die ("aging of an adult organism"). It turned out that modification of the initial part of the curve by various methods inevitably entails changes in its second part, which described the aging and death of cells.
To conclude, I would like to note the following. Unfortunately, as far as I know, the vast majority of the studies aimed at investigating the relationship between the proliferation kinetics of cultured animal and human cells and aging were performed in the 1970s-1980s. At the same time, it seems to me that the "cell kinetic" approach to the experimental gerontological studies in recent years lost the attention of specialists undeservedly and requires "rehabilitation." Of course, this will require further development of the abovementioned models (in particular, in terms of development of an appropriate mathematical apparatus, which could not only shed light on some of the patterns of aging of multicellular organisms but also improve the efficiency of search for new geroprotectors). As for the problem of selecting the optimal objects for such studies, in my opinion, the normal immortalized human cells are most promising in this regard [42] . They are not cancerous but have an unlimited mitotic potential. It is such kind of cells we plan to use in our experiments in the near future. ACKNOWLEDGMENTS I am grateful to G.V. Morgunova and A.A. Klebanov for assistance in preparing the manuscript. The study was performed under the state assignment to Moscow State University, part 2 (basic research, no. AAAA-A16-116021660098-8).
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